Wilson CH et al. |
Prospective randomised trial of the use of Daclizumab in renal transplantation using kidneys from non heart beating donors. |
2004 |
Ann. Transplant. |
pmid:15478912
|
Muraki Y et al. |
Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients. |
2011 Oct-Dec |
Ann. Transplant. |
pmid:22210422
|
Boratyńska M et al. |
Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. |
2006 |
Ann. Transplant. |
pmid:17494290
|
Foroncewicz B et al. |
A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up. |
2013 |
Ann. Transplant. |
pmid:23896824
|
Grochowiecki T et al. |
A retrospective study of steroid elimination in simultaneous pancreas and preemptive kidney transplant (Sppre-Ktx) recipients. |
2006 |
Ann. Transplant. |
pmid:17494291
|
Arreola-Guerra JM et al. |
Tacrolimus Trough Levels as a Risk Factor for Acute Rejection in Renal Transplant Patients. |
2016 |
Ann. Transplant. |
pmid:26879833
|
Mocchegiani F et al. |
Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis. |
2014 |
Ann. Transplant. |
pmid:25347718
|
Fox BD et al. |
Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients. |
2017 |
Ann. Transplant. |
pmid:29133776
|
Rehman S et al. |
Effect of different tacrolimus levels on early outcomes after kidney transplantation. |
2014 |
Ann. Transplant. |
pmid:24509826
|
Legris T et al. |
Humoral immunity after kidney transplantation: impact of two randomized immunosuppressive protocols. |
2013 |
Ann. Transplant. |
pmid:24231646
|
Hakeam HA et al. |
Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients. |
2008 |
Ann. Transplant. |
pmid:18566560
|
Bäckman L and Persson CA |
An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients. |
2014 |
Ann. Transplant. |
pmid:24637379
|
Girman P et al. |
The effect of bone marrow transplantation on survival of allogeneic pancreatic islets with short-term tacrolimus conditioning in rats. |
2001 |
Ann. Transplant. |
pmid:11803619
|
Steinebrunner N et al. |
Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study. |
2014 |
Ann. Transplant. |
pmid:24457606
|
Wu YJ et al. |
Safe One-to-One Dosage Conversion From Twice-Daily to Once-Daily Tacrolimus in Long-Term Stable Recipients After Liver Transplantation. |
2016 |
Ann. Transplant. |
pmid:26782179
|
Gijsen VM et al. |
Tacrolimus-induced nephrotoxicity and genetic variability: a review. |
2012 Apr-Jun |
Ann. Transplant. |
pmid:22743729
|
Urbanowicz T et al. |
Induction therapy, tacrolimus plasma concentration, and duration if intensive care unit stay are risk factors for peripheral leucopenia following heart transplantation. |
2014 |
Ann. Transplant. |
pmid:25274118
|
Czubkowski P et al. |
Cardiovascular risk factors after conversion from cyclosporine to tacrolimus in children after liver transplantation. |
2014 |
Ann. Transplant. |
pmid:25409773
|
Baron PW et al. |
Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression. |
2017 |
Ann. Transplant. |
pmid:28533501
|
Furmańczyk A et al. |
Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation. |
2009 Oct-Dec |
Ann. Transplant. |
pmid:20009155
|
Gerlach UA et al. |
Aspergillus spondylodiscitis after multivisceral transplantation. |
2009 Oct-Dec |
Ann. Transplant. |
pmid:20009156
|
Aguiar D et al. |
Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients. |
2017 |
Ann. Transplant. |
pmid:28461684
|
Malinowski M et al. |
Effect of tacrolimus dosing on glucose metabolism in an experimental rat model. |
2010 Jul-Sep |
Ann. Transplant. |
pmid:20877268
|
Roan JN et al. |
Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation. |
2013 |
Ann. Transplant. |
pmid:23792500
|
Tanaka T et al. |
Evaluation of immune function under conversion from Prograf to Advagraf in living donor liver transplantation. |
2013 |
Ann. Transplant. |
pmid:23792533
|
Ueda K et al. |
Early corticosteroid withdrawal in the real world: a long-term analysis of kidney transplant recipients from the Mycophenolic Acid Observational Renal Transplant Registry. |
2014 |
Ann. Transplant. |
pmid:24535029
|
El-Agroudy AE et al. |
Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications. |
2008 |
Ann. Transplant. |
pmid:19034223
|
Augusto JF et al. |
Long-term maintenance immunosuppressive regimen with tacrolimus monotherapy. |
2013 |
Ann. Transplant. |
pmid:23872516
|
Miyata Y et al. |
Pharmacokinetics of a Once-Daily Dose of Tacrolimus Early After Liver Transplantation: With Special Reference to CYP3A5 and ABCB1 Single Nucleotide Polymorphisms. |
2016 |
Ann. Transplant. |
pmid:27503662
|
Mizuno S et al. |
Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients. |
2013 |
Ann. Transplant. |
pmid:23845965
|
Kuypers DR |
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring. |
2008 |
Ann. Transplant. |
pmid:18806728
|
Grenda R et al. |
Evaluation of the genetic background of standard-immunosuppressant-related toxicity in a cohort of 200 paediatric renal allograft recipients--a retrospective study. |
2009 Jul-Sep |
Ann. Transplant. |
pmid:19644155
|
Basu A et al. |
Outcomes of renal transplantation in recipients with peak panel reactive antibody >30% under tacrolimus-based immunosuppression. |
2011 Jul-Sep |
Ann. Transplant. |
pmid:21959503
|
Fukazawa K et al. |
Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation. |
2011 Jul-Sep |
Ann. Transplant. |
pmid:21959523
|
Zegarska J et al. |
Mycophenolic Acid Metabolites Acyl-Glucuronide and Glucoside Affect the Occurrence of Infectious Complications and Bone Marrow Dysfunction in Liver Transplant Recipients. |
2015 |
Ann. Transplant. |
pmid:26313036
|
Figurski MJ et al. |
Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: correlation the side-effects and rejections with pharmacokinetic parameters. |
2012 Jan-Mar |
Ann. Transplant. |
pmid:22466911
|
Acott P and Babel N |
BK virus replication following kidney transplant: does the choice of immunosuppressive regimen influence outcomes? |
2012 Jan-Mar |
Ann. Transplant. |
pmid:22466913
|
Bułanowski M et al. |
Influence of conversion from cyclosporine A to tacrolimus on insulin sensitivity assessed by euglicaemic hyperinsulinemic clamp technique in patients after kidney transplantation. |
2012 Jul-Sep |
Ann. Transplant. |
pmid:23018257
|
Schmid S et al. |
Volatility of serum creatinine relative to tacrolimus levels predicts kidney transplant rejection. |
2014 |
Ann. Transplant. |
pmid:25123847
|
Baran DA and Galin ID |
"One size fits all": immunosuppression in cardiac transplantation. |
2003 |
Ann. Transplant. |
pmid:12848376
|
Remiszewski P et al. |
Orthotopic liver transplantation for acute liver failure resulting from "acute fatty liver of pregnancy". |
2003 |
Ann. Transplant. |
pmid:15114933
|
Dedinská I et al. |
Waist circumference as an independent risk factor for NODAT. |
2015 |
Ann. Transplant. |
pmid:25791039
|
Eguchi S et al. |
Intentional conversion from tacrolimus to cyclosporine for HCV-positive patients on preemptive interferon therapy after living donor liver transplantation. |
2007 |
Ann. Transplant. |
pmid:18344932
|
Zahn A et al. |
Mycophenolate mofetil combination therapy improves survival after liver transplantation. A single-center retrospective analysis. |
2013 |
Ann. Transplant. |
pmid:24088725
|
Garaix F et al. |
Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study. |
2018 |
Ann. Transplant. |
pmid:30093607
|
WÅ‚odarczyk Z et al. |
Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients. |
2002 |
Ann. Transplant. |
pmid:12465429
|
Matia I et al. |
Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats. |
2014 |
Ann. Transplant. |
pmid:24815872
|
Gardiner KM et al. |
Multinational Evaluation of Mycophenolic Acid, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus Utilization. |
2016 |
Ann. Transplant. |
pmid:26729299
|
Park S et al. |
Reduced Tacrolimus Trough Level Is Reflected by Estimated Glomerular Filtration Rate (eGFR) Changes in Stable Renal Transplantation Recipients: Results of the OPTIMUM Phase 3 Randomized Controlled Study. |
2018 |
Ann. Transplant. |
pmid:29891834
|
Rostaing L et al. |
The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study. |
2014 |
Ann. Transplant. |
pmid:25017487
|
Jannot M et al. |
Early conversion from twice-daily tacrolimus to once-daily extended formulation in renal transplant patients before hospital discharge. |
2014 |
Ann. Transplant. |
pmid:24999809
|
Provenzani A et al. |
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients. |
2009 Jan-Mar |
Ann. Transplant. |
pmid:19289993
|
Urbanowicz T et al. |
Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation. |
2014 |
Ann. Transplant. |
pmid:24949728
|
Tang JT et al. |
A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients. |
2018 |
Ann. Transplant. |
pmid:29735966
|
Fuchs U et al. |
Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus. |
2014 |
Ann. Transplant. |
pmid:24953848
|
Hošková L et al. |
Comparison of Cystatin C and NGAL in Early Diagnosis of Acute Kidney Injury After Heart Transplantation. |
2016 |
Ann. Transplant. |
pmid:27226081
|
Abdel Halim M et al. |
Toxic tacrolimus blood levels with rifampin administration in a renal transplant recipient. |
2010 Jan-Mar |
Ann. Transplant. |
pmid:20305320
|
Wu P et al. |
Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients. |
2011 Jan-Mar |
Ann. Transplant. |
pmid:21436775
|
Foroncewicz B et al. |
Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis. |
2014 |
Ann. Transplant. |
pmid:25163829
|
Bösmüller C et al. |
Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial. |
2012 |
Ann. Transplant. |
pmid:23274323
|
Olczak-Kowalczyk D et al. |
The status of dental and jaw bones in children and adolescents after kidney and liver transplantation. |
2012 |
Ann. Transplant. |
pmid:23274327
|
Zakliczyński M et al. |
Clinical application of monitoring mycophenolic acid trough concentration in heart transplant recipients--single center's experience. |
2005 |
Ann. Transplant. |
pmid:16218032
|
Mahalati K and Kahan BD |
Pharmacological surrogates of allograft outcome. |
2000 |
Ann. Transplant. |
pmid:11217202
|
Garlicki M et al. |
Conversion from cyclosporine to tacrolimus improves renal function and lipid profile after cardiac transplantation. |
2006 |
Ann. Transplant. |
pmid:17025026
|
Ruangkanchanasetr P et al. |
Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients. |
2016 |
Ann. Transplant. |
pmid:27980321
|
Malinowski M et al. |
The influence of commonly used immunosuppressive drugs on the small bowel functions - a comparative experimental study. |
2009 Apr-Jun |
Ann. Transplant. |
pmid:19487793
|
Kitazawa F et al. |
Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. |
2017 |
Ann. Transplant. |
pmid:28947731
|
Kishida N et al. |
Increased Incidence of Thrombotic Microangiopathy After ABO-Incompatible Living Donor Liver Transplantation. |
2016 |
Ann. Transplant. |
pmid:27956735
|
Hirano Y et al. |
Prolonged Administration of Twice-Daily Bolus Intravenous Tacrolimus in the Early Phase After Lung Transplantation. |
2017 |
Ann. Transplant. |
pmid:28798289
|
Illsinger S et al. |
Effect of tacrolimus on energy metabolism in human umbilical endothelial cells. |
2011 Apr-Jun |
Ann. Transplant. |
pmid:21716189
|
Duvoux C et al. |
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection. |
2015 |
Ann. Transplant. |
pmid:25588713
|
Mijal J et al. |
Formation of synapses between dendritic cells and lymphocytes in skin lymph in an allogeneic reaction. |
2002 |
Ann. Transplant. |
pmid:12854345
|
Albano L et al. |
Dosing of Enteric-Coated Mycophenolate Sodium Under Routine Conditions: An Observational, Multicenter Study in Kidney Transplantation. |
2016 |
Ann. Transplant. |
pmid:27122116
|
Thölking G et al. |
Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation. |
2016 |
Ann. Transplant. |
pmid:27003330
|
Snell GI et al. |
Evolution to twice daily bolus intravenous tacrolimus: optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant. |
2013 |
Ann. Transplant. |
pmid:23921892
|
Wyzgał J et al. |
Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors. |
2007 |
Ann. Transplant. |
pmid:18173063
|
McCourtie AS et al. |
Synergistic protection in lung ischemia-reperfusion injury with calcineurin and thrombin inhibition. |
2010 |
Ann. Thorac. Surg. |
pmid:20494024
|
Laubach VE |
Invited commentary. |
2010 |
Ann. Thorac. Surg. |
pmid:20494025
|
Li S et al. |
Intrathymic inoculation of donor bone marrow induces long-term acceptance of lung allografts. |
2003 |
Ann. Thorac. Surg. |
pmid:12537225
|
Sugita M et al. |
Pharmacologic modulation of alveolar liquid clearance in transplanted lungs by phentolamine and FK506. |
2009 |
Ann. Thorac. Surg. |
pmid:19699927
|
Moffatt-Bruce S |
Invited commentary. |
2009 |
Ann. Thorac. Surg. |
pmid:19699928
|
Thyagarajan GK et al. |
FK506-induced fulminant leukoencephalopathy after single-lung transplantation. |
1997 |
Ann. Thorac. Surg. |
pmid:9386723
|
Leshnower BG et al. |
Cyclosporine preserves mitochondrial morphology after myocardial ischemia/reperfusion independent of calcineurin inhibition. |
2008 |
Ann. Thorac. Surg. |
pmid:18805178
|
Chambers DJ |
Invited commentary. |
2008 |
Ann. Thorac. Surg. |
pmid:18805179
|
Nathan M et al. |
Cyclosporin A but not FK-506 protects against dopamine-induced apoptosis in the stunned heart. |
2005 |
Ann. Thorac. Surg. |
pmid:15854943
|
Hirai T et al. |
A short course of FK506 can induce limited donor-specific graft acceptance. |
1994 |
Ann. Thorac. Surg. |
pmid:7520685
|
Armitage JM et al. |
Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. |
1992 |
Ann. Thorac. Surg. |
pmid:1379032
|
Oto T et al. |
Calcineurin inhibitor-related cholestasis complicating lung transplantation. |
2010 |
Ann. Thorac. Surg. |
pmid:20417810
|
Groetzner J et al. |
Cardiac transplantation in pediatric patients: fifteen-year experience of a single center. |
2005 |
Ann. Thorac. Surg. |
pmid:15620914
|
Inutsuka K et al. |
Reconstruction of trachea and carina with immediate or cryopreserved allografts in dogs. |
1996 |
Ann. Thorac. Surg. |
pmid:8893587
|
Bolman RM |
Advantage--FK 506: reduced chronic rejection for lung transplant recipients. |
1995 |
Ann. Thorac. Surg. |
pmid:7545888
|
Keenan RJ et al. |
Clinical trial of tacrolimus versus cyclosporine in lung transplantation. |
1995 |
Ann. Thorac. Surg. |
pmid:7545889
|
Todo S et al. |
Liver, kidney, and thoracic organ transplantation under FK 506. |
1990 |
Ann. Surg. |
pmid:1697743
|
Shapiro R et al. |
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. |
2003 |
Ann. Surg. |
pmid:14530723
|
Petruzzo P et al. |
Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis. |
2015 |
Ann. Surg. |
pmid:24646555
|
Todo S et al. |
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. |
1994 |
Ann. Surg. |
pmid:7522431
|
Jain A et al. |
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. |
1999 |
Ann. Surg. |
pmid:10493490
|
Lerut J et al. |
Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. |
2008 |
Ann. Surg. |
pmid:19092340
|
Bartlett ST et al. |
Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. |
1996 |
Ann. Surg. |
pmid:8857849
|
Todo S et al. |
Intestinal transplantation in composite visceral grafts or alone. |
1992 |
Ann. Surg. |
pmid:1384443
|